News | December 14, 2023
Venus Remedies expands global presence with marketing authorisation for enoxaparin from Azerbaijan
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
PEEK brings a new quality to dental care for patients
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Subscribe To Our Newsletter & Stay Updated
